---
title: "Fluphenazine Enanthate - Schizophrenia - 2"
sidebar: mydoc_sidebar
permalink: db00623-mesh-d012559-2.html
toc: false 
---


Path ID: `DB00623_MESH_D012559_2`
{% include image.html url="images/db00623-mesh-d012559-2.png" file="db00623-mesh-d012559-2.png" alt="db00623-mesh-d012559-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C017610 | fluphenazine enanthate | Drug |
| UniProt:P14416 | dopamine D2 receptor | Protein |
| GO:0061527 | dopamine secretion, neurotransmission | BiologicalProcess |
| UBERON:0001017 | central nervous system | GrossAnatomicalStructure |
| InterPro:IPR022423 | Neurohypophysial hormone | GeneFamily |
| HP:0000708 | Behavioral abnormality | PhenotypicFeature |
| MESH:D012559 | Schizophrenia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Fluphenazine Enanthate | DECREASES ACTIVITY OF | Dopamine D2 Receptor |
| Dopamine D2 Receptor | POSITIVELY CORRELATED WITH | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | LOCATED IN | Central Nervous System |
| Central Nervous System | CORRELATED WITH | Neurohypophysial Hormone |
| Neurohypophysial Hormone | CORRELATED WITH | Behavioral Abnormality |
| Behavioral Abnormality | POSITIVELY CORRELATED WITH | Schizophrenia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00623](https://go.drugbank.com/drugs/DB00623)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/3372](https://pubchem.ncbi.nlm.nih.gov/compound/3372)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL726/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL726/)
  - [https://en.wikipedia.org/wiki/Fluphenazine](https://en.wikipedia.org/wiki/Fluphenazine)
